Table 2.
Association of LINC00096 Expression with Clinicopathological Parameters of Breast Cancer Patients
| Characteristic | No. | LINC00096 Relative Expression Level | χ2 | P Value | |
|---|---|---|---|---|---|
| High (%) | Low (%) | ||||
| Age (y) | 0.216 | 0.739 | |||
| ≤50 | 48 (53.3) | 26 (28.9) | 22 (24.4) | ||
| >50 | 42 (46.7) | 24 (26.7) | 18 (20.0) | ||
| Tumor stage | 4.768 | 0.021* | |||
| I-II stage | 39 (43.3) | 14 (15.6) | 25 (27.8) | ||
| III-IV stage | 51 (56.7) | 38 (42.2) | 13 (14.4) | ||
| Lymphatic metastasis | 8.963 | 0.001* | |||
| Positive | 34 (37.8) | 26 (28.9) | 8 (8.9) | ||
| Negative | 56 (62.2) | 25 (27.8) | 31 (34.4) | ||
| Tumor size | 0.431 | 0.073 | |||
| ≤5cm | 43 (47.8) | 23 (25.6) | 20 (22.2) | ||
| >5cm | 47 (52.2) | 29 (32.2) | 18 (20.0) | ||
| Distant metastasis | 2.543 | 0.034* | |||
| M0 | 69 (76.7) | 32 (35.6) | 37 (41.1) | ||
| M1 | 21 (23.3) | 17 (18.9) | 4 (4.4) | ||
| Histological differentiation | 1.076 | 0.026* | |||
| Low-grade | 23 (25.6) | 12 (13.3) | 11 (12.2) | ||
| Middle-grade | 35 (38.9) | 25 (27.8) | 10 (11.1) | ||
| High-grade | 32 (35.5) | 21 (23.3) | 11 (12.2) | ||
| Ki-67 level | 2.963 | 0.047* | |||
| ≤10 | 57 (63.3) | 25 (27.8) | 32 (35.6) | ||
| >10 | 33 (36.7) | 26 (28.9) | 7 (7.8) | ||
Note: *P<0.05.